Yadong Lu
Papers
1
Total Citations
14
H-Index
1
About
Yadong Lu is a clinical researcher whose work focuses on urological oncology, particularly prostate cancer prognostics. His most-cited study, published in 2019, evaluated the neutrophil-to-lymphocyte ratio (NLR) as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy. This research, with 14 citations, contributes to the growing body of evidence exploring inexpensive, readily available blood-based biomarkers for cancer outcomes. By analyzing a specific Asian population, Lu’s work addresses critical gaps in personalized risk stratification, highlighting how inflammatory markers may predict recurrence or progression after surgery. His findings underscore the potential of NLR to complement traditional clinical factors, offering a non-invasive tool for guiding post-treatment surveillance. Lu’s research is particularly valuable for clinicians and researchers seeking to improve prognostic accuracy in diverse ethnic groups, advancing the goal of tailored oncological care.
Research Focus
Key Achievements
Top Papers
- 1